SHENZHEN, China, Nov. 21 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited , a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced that it will attend the 2007 Radiological Society of North America (RSNA) Conference in Chicago, Illinois at the McCormick Place from November 25 to 30, 2007. Mindray’s exhibition booth will be located in the South Building, Hall A, #3159.
''We will be showcasing two new products at the RSNA Conference, including our portable M5 and DC-3 diagnostic ultrasound systems,’' said Mr. Xu Hang, Mindray’s chairman and co-chief executive officer. “The high-functionality, competitively-priced M5 is our first portable color ultrasound imaging system and is tailored for North American and European markets. We are also excited to introduce our color DC-3 diagnostic ultrasound system, which holds significant market potential in China and in developing markets around the world.’'
The company expects to launch both the DC-3 and portable M5 diagnostic ultrasound systems globally at the end of 2007, excluding the U.S. In the U.S., the products will be launched as soon as they receive U.S. Food and Drug Administration (FDA) 510k clearance.
Mr. Minghe Cheng, Mindray’s executive vice president of strategic development and Mr. Jie Liu, Mindray’s executive vice president of international sales & marketing will attend the event.
http://rsna2007.rsna.org
About Mindray
Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in China with a significant and growing presence worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems. Mindray is headquartered in Shenzhen, China, and has 29 local sales and service offices in China, as well as sales and service offices in Amsterdam, Boston, Istanbul, London, Mexico City, Mumbai, Sao Paulo, Seattle, Toronto and Vancouver. For more information, please visit http://www.mindray.com .
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the ''safe harbor’’ provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as ''will,’' ''expects,’' ''anticipates,’' ''future,’' ''intends,’' ''plans,’' ''believes,’' ''estimates,’' ''confident’’ and similar statements. Statements that are not historical facts, including statements about Mindray’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Information regarding these risks and uncertainties is included in our public filings with the Securities and Exchange Commission. All information provided in this press release is as of November 21, 2007, and Mindray undertakes no duty to update such information, except as required under applicable law.
IR@Mindray.comJustin.Knapp@Ogilvy.com
CONTACT: Investor Relations of Mindray Medical International Limited,
+86-755-2658-2518, or IR@Mindray.com (In China); or Justin Knapp of Ogilvy
Public Relations Worldwide, Beijing, +86-10-8520-6556, or
Justin.Knapp@Ogilvy.com; or Jeremy Bridgman of Ogilvy Public Relations
Worldwide, New York, +1-212-880-5363 (In the United States)
Web site: http://rsna2007.rsna.org/
http://www.mindray.com/
